Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Clinical trial NCT07299695 · RECRUITING
Trial details
- NCT number
- NCT07299695
- Sponsor
- Argyrios Tzouvelekis
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-25
- Primary completion
- 2028-06-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.